Literature DB >> 1479458

Dysphoric distress in childbearing women.

D D Affonso1, S Lovett, S Paul, S Sheptak, R Nussbaum, L Newman, B Johnson.   

Abstract

Previous research on depression in childbearing women has focused on the presence or absence of clinical depression. Little attention has been paid to the distress caused by the presence of depressive symptoms in the absence of the full syndrome of clinical depression. A convenience sample of 202 healthy, married, primigravid women who were free of psychiatric symptoms were assessed at 10 to 14 weeks and 30 to 32 weeks of pregnancy and at 1 to 2 weeks and 14 weeks post partum. Depression symptoms were measured by using the Schedule of Affective Disorders and Schizophrenia, the standardized clinical interview for research and depression of The National Institute of Mental Health. Data from the Schedule of Affective Disorders and Schizophrenia indicated that only 5% of the women met criteria for clinical depression but approximately 50% of the sample reported clinical levels of three or more depressive symptoms. Anger, fatigue, psychic anxiety, and worry were the most frequently endorsed symptoms at each assessment point. The implications of these findings for symptom management and health promotion for childbearing women are discussed.

Entities:  

Mesh:

Year:  1992        PMID: 1479458

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  2 in total

1.  The emotional-behavioural functioning of children exposed to maternal depressive symptoms across pregnancy and early childhood: a prospective Australian pregnancy cohort study.

Authors:  Rebecca Giallo; Hannah Woolhouse; Deirdre Gartland; Harriet Hiscock; Stephanie Brown
Journal:  Eur Child Adolesc Psychiatry       Date:  2015-01-09       Impact factor: 4.785

2.  Detection of postpartum depression and anxiety in a large health plan.

Authors:  Ashley O Coates; Catherine A Schaefer; Jeanne L Alexander
Journal:  J Behav Health Serv Res       Date:  2004 Apr-Jun       Impact factor: 1.505

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.